Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Regulation of Hormone Secretion01:19

Regulation of Hormone Secretion

6.0K
Regulation of hormone secretion is a finely tuned orchestration driven by various types of stimuli, encompassing neural, humoral, and hormonal signals. Environmental cues instigate neural stimuli, where action potentials traverse nerve fibers to reach their designated targets. An illustrative scenario is the body's response to stress, wherein the sympathetic nervous system releases epinephrine from the adrenal glands, inducing the well-known 'fight or flight' reaction.
Humoral...
6.0K
Hormonal Regulation01:40

Hormonal Regulation

47.7K
Hormones regulate a significant portion of digestion through activation of the neuroendocrine system. The neuroendocrine system of digestion contains many different hormones all with multiple functions that are both, directly and indirectly, involved in digestion.
47.7K
Overview of Secretory Vesicles01:33

Overview of Secretory Vesicles

9.3K
Secretory vesicles, also known as dense core vesicles (DCVs), are membrane-bound vesicles that transport secretory proteins, such as hormones or neurotransmitters. Regulated secretory vesicles transport proteins from the trans-Golgi network to the exterior of the cell. Proteins present in regulated secretory vesicles are required to be rapidly exocytosed in large amounts upon a specific stimulus.
Various proteins regulate the aggregation of molecules inside the secretory vesicles. Chromogranins...
9.3K
Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

6.3K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
6.3K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

2.1K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
2.1K
Feedback Inhibition00:46

Feedback Inhibition

56.8K
Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
56.8K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

IDH1-R132H enhances oncolytic HSV-1 therapy by facilitating viral entry and immune activation in glioma.

Nature communications·2026
Same author

A cell-intrinsic glucocorticoid biosynthesis and sensing circuit maintains a homeostatic Th17 cell state.

Immunity·2026
Same author

Interleukin 23 promotes a pro-inflammatory Th17 cell state by stabilizing RORγt and suppressing glucocorticoid receptor activity.

Immunity·2026
Same author

Cell-type- and state-resolved transcriptomics uncovers distinct T cell and monocyte dysregulation in multiple sclerosis.

Cell reports·2026
Same author

An adaptive cellular source of IL-17A and IL-17F is critical for the induction of experimental autoimmune encephalomyelitis.

Science immunology·2026
Same author

The dual role of TOX in regulating T<sub>H</sub>1 and CD8<sup>+</sup> T cell fate.

Nature immunology·2026

Video Experimental Relacionado

Updated: Jan 9, 2026

Regulation of Hormone Secretion
01:19

Regulation of Hormone Secretion

6.0K

Bloqueo de la IL-17 en la psoriasis

Patrick R Burkett1, Vijay K Kuchroo2

  • 1Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham & Women's Hospital, Boston, MA 02115, USA; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham & Women's Hospital, Boston, MA 02115, USA.

Cell
|December 17, 2016
PubMed
Resumen

La interleucina-17A (IL-17A) conduce a la inflamación autoinmune. Los anticuerpos monoclonales secukinumab e ixekizumab dirigidos a IL-17A están aprobados para la psoriasis y afecciones relacionadas.

Más Videos Relacionados

Hormonal Regulation of Digestion
01:40

Hormonal Regulation of Digestion

47.7K
Overview of Secretory Vesicles
01:33

Overview of Secretory Vesicles

9.3K

Videos de Experimentos Relacionados

Last Updated: Jan 9, 2026

Regulation of Hormone Secretion
01:19

Regulation of Hormone Secretion

6.0K
Hormonal Regulation of Digestion
01:40

Hormonal Regulation of Digestion

47.7K
Overview of Secretory Vesicles
01:33

Overview of Secretory Vesicles

9.3K

Área de la Ciencia:

  • Inmunología
  • Reumatología
  • Dermatología

Sus antecedentes:

  • La interleucina-17A (IL-17A) es una citocina clave que media la inflamación del tejido autoinmune.
  • La IL-17A induce directamente la inflamación y sinergiza con otras citoquinas inflamatorias.

Objetivo del estudio:

  • Revisar las aplicaciones terapéuticas de los inhibidores de la IL-17A.
  • Para resaltar la eficacia de secukinumab e ixekizumab en el tratamiento de enfermedades inflamatorias.

Principales métodos:

  • Revisión de los datos de los ensayos clínicos y las aprobaciones reglamentarias.
  • Análisis del mecanismo de acción de los anticuerpos monoclonales IL-17A.

Principales resultados:

  • El secukinumab y el ixekizumab, como anticuerpos monoclonales (mAb), inhiben eficazmente la IL-17A.
  • Ambos agentes están aprobados para el tratamiento de la psoriasis.
  • Secukinumab también está aprobado para la artritis psoriásica y la espondilitis anquilosante.

Conclusiones:

  • La orientación de la IL-17A con anticuerpos monoclonales representa un avance significativo en el tratamiento de enfermedades autoinmunes e inflamatorias.
  • El secukinumab y el ixekizumab ofrecen opciones terapéuticas efectivas para pacientes con psoriasis y espondiloartropatías.